Company CVAbout Senores Pharmaceuticals Ltd 
Senores Pharmaceuticals Ltd
Small Cap
Pharmaceuticals & Biotechnology
Senores Pharmaceuticals Limited was originally incorporated as "Senores Pharmaceuticals Private Limited" through a Certificate of Incorporation dated December 26, 2017, issued by the Registrar of Companies, Central Registration Centre. Thereafter, the name of the Company was changed to "Senores Pharmaceuticals Limited" upon conversion to a Public Limited Company and a fresh Certificate of Incorporation dated September 4, 2023, was issued by the RoC to the Company.
Company Coordinates
No Company Details Available
Capital StructureCapital Structure
Present Equity Capital
INR None Cr
Number of Shares
None Cr
Face Value
INR None
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
No Details Available.
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 5 Schemes (3.54%)
FIIs
Held by 25 FIIs (4.28%)
Promoter with highest holding
Swapnil Jatin Shah (7.72%)
Highest Public shareholder
Aditya Birla Sun Life Insurance Company Limited (2.94%)
Individual Investors Holdings
31.09%
Board of Directors
Management
Designation
Remuneration
No Data
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
No Data Available for Finished Goods Segmentation
No Data Available
Stock DNARevenue and Profits:
Net Sales:
162 Cr
(Quarterly Results - Sep 2025)
Net Profit:
32 Cr
Pharmaceuticals & Biotechnology
INR 3,556 Cr (Small Cap)
61.00
34
0.00%
0.05
7.19%
4.44
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
